Life Science Success

Send us a textIn this episode of Life Science Success, I am interviewing one of the world’s leading business thinkers, Dr. David Burkus’ forward-thinking ideas and bestselling books are helping leaders build their best team ever.   Dr. David Burkus discusses the challenges of remote and hybrid work environments and the importance of deliberate leadership He emphasizes the need for fair feedback, giving feedback in proportion to how someone is doing Dr. Burkus also stresses the importance of micro praises and the need to be deliberate about recognizing employees' successes He believes that many organizations are approaching remote and hybrid work in the wrong way and need to have a broader conversation about the type of work that should happen in the office versus remotely Dr. Burkus is inspired to make work not suck and wants to help organizations tap into their employees' potential He also discusses his course, "Build Your Best Team Ever," which provides research-based actions for team leaders to improve their teams' dynamics and productivity

Send us a textIn this episode of Life Science Success, my guest is Ketan Mehta, the founder and CEO of Tris Pharma. Under his leadership, Tris Pharma has developed many innovative technologies, launched new products, and established itself as a leader among technology-driven pharmaceutical companies.  Ketan Mehta discusses the importance of being open to change and feedback in building successful companies Patient feedback has directly influenced Tris Pharma's product development Ketan Mehta believes that the pharmaceutical industry will evolve significantly in the next decade, particularly with the rise of personalized medicine and digital health He offers advice for aspiring entrepreneurs in the life sciences, emphasizing the need for clear motivation, commitment, and a focus on making a positive impact Ketan Mehta is excited about the future possibilities and the potential for significant change in the next few decades

Send us a textThis week on the Life Science Success podcast, my guest is Thomas Farb-Horch.  Thomas is the CEO of Thrive Bio.  He has been involved in the founding of 18 pharmaceutical, biotech, medtech, software, and AI companies, 7 of which have been unicorns. Currently, he is CEO and Co-Founder of Boston-based Thrive Bioscience, which commercializes instruments and software for a critically important but neglected area of life sciences, which is imaging, analytics, and automation of cell culture, cell-based research, and cell therapeutics.   Thomas Forest Farb-Horch has experience automating cytology labs and now seeks to improve cell culture labs through Thrive. Thrive aims to improve the low chances of therapeutics getting from bench to patient by transforming cell biology. Thrive's technology collects large, comparable data sets that make better cells, which is important for bringing cell therapeutics to the market. Thrive's data sets and images are valuable to researchers because they can see things that they never saw before and make faster decisions. Thrive is transforming viral plaque assay, which is the standard way of studying viruses, and can now track plaques from day 2 instead of waiting for weeks. Thomas is concerned about divisiveness, duality, and false dualities, and the lack of equality of opportunity, education, and health. Thomas is excited about solving big, ignored problems and changing the world.

Send us a textIn this episode of the Life Science Success Podcast, my guest is Artem Britchenko.  Artem is the CEO of Platforce, which helps companies that interact with healthcare professionals and care about the efficiency and compliance of these interactions. He has been working in the B2C Pharma industry, helping companies improve their sales force effectiveness, customer engagement, and customer centricity.     Don Davis, PhD, MBA interviews Artem Brytchenko, CEO of Platforce Platforce is a CRM solution tailored to the unique needs of the life sciences industry The solution includes closed loop marketing, remote capabilities, consent collection, distributor order optimization, and more The biggest challenges faced by Platforce include constant innovation and adaptation, scaling operations, and managing a global, distributed team The biggest opportunities include the rapid digital transformation of the life sciences industry, expanding to new geographies and markets, and serving adjacent sectors within healthcare Artem is inspired by his team, challenges, and family, concerned about the rapidly changing technological landscape and global complexities, and excited about fostering innovation and collaboration, technological advancements, and personal growth and happiness

Send us a textIn this episode of Life Science Success, my guest is Rohit Sood  EVP, COMPLETE Commercialization at EVERSANA.  He is a life sciences strategy and operations executive with a passion for developing teams and solving business challenges. Track record of driving topline business growth while identifying significant operational efficiencies in PE-backed, startup, and publicly-listed organizations.   Rohit Sood and Don Davis discuss challenges faced by organizations during the commercialization phase Eversana helps smaller biotechs evaluate the process of commercialization and provides support through it Good leadership inspires Rohit, and he values transparency and clarity in decision-making Short-term thinking and not listening to advisors concerns Rohit Traveling and food excite Rohit

Send us a textIn this episode of Life Science Success, I am joined by Daniel Thadani the Head of Retail and Tenders for IPCA Laboratories Limited.  Daniel is based in Kyiv, Ukraine 🇺🇦.  He is responsible for  business promotion and development, sales forecasting, distribution management, marketing coordination with head office, pricing, product registration through a third party, team hiring, and management.   Daniel Thadani worked as a country head in Kazakhstan for five and a half years He describes the differences in medical affairs, regulatory, people management, distribution, and the overall landscape of pharma in Central Asia Thadani emphasizes the importance of trust and integrity in leadership He works for IPCA Laboratories, a top-notch pharma company that produces branded generic products with 350 formulations and 80 APIs in various therapeutic areas IPCA has a solid footprint in Africa, South America, and Southeast Asia and is a world leader in APIs Thadani discusses the resilience of the pharma business in Ukraine during the COVID-19 pandemic and war He is concerned about indecency and political approaches in people, as well as discrepancies in numbers Thadani is excited by complex situations with a positive impact on his immediate ecosystem  

Send us a textIn this episode of Life Science Success, my guest is Nusqe Spanton.  Nusqe is the founder and CEO of Provectus Algae. He is an aquaculture and algae expert with nearly two decades of experience working in international aquacultural production, marine biotechnology, and corporate management.   Nusqe Spanton discusses the potential of marine microorganisms to produce commercially valuable compounds. The company, Provectus, is focused on developing products for food, agriculture, and cosmetics, as well as oral fertility treatments. The company is still in an early phase of development and has around 30 employees. Spanton emphasizes the importance of making quick and decisive decisions as a leader, especially in a startup environment. He also stresses the need to move quickly in addressing environmental concerns. Spanton is inspired by his children and the potential of the younger generation to effect change. He is excited about building a great business with like-minded individuals and being a problem solver.  

Send us a textIn this episode of Life Science Success, my guest is John Alderete. Dr. Alderete has successfully applied his wide range of experience and formal training to the evaluation, financing, formation, and operation of diagnostics and medical device technology companies. Don Davis and John Alderete discuss pitching scientific research to investors Davis emphasizes tailoring pitches to the audience and understanding investors' perspective Alderete stresses the importance of having the right team and being honest about limitations Alderete expresses concern about lack of progress in biological surveillance and potential for future pandemics Alderete is excited about modern tools and technologies available to younger generation of scientists The conversation offers insights on challenges of pitching research, importance of team, and need for better pandemic preparation It highlights exciting possibilities in modern tools and technologies for younger scientists.    

Send us a textIn this episode of Life Science Success, my guest is Dr. Helen Torley.  Dr. Torley is the President and CEO of Halozyme. Halozyme's innovative and disruptive solutions provide new therapeutic options that could significantly improve the patient experience by changing how treatments are delivered.  Dr. Helen Torley, CEO of Halozyme, discusses the company's dedication to improving patient experiences and outcomes through their research and development of monoclonal antibodies and small molecules. Halozyme places a strong emphasis on corporate culture, including cross-functional collaboration and community outreach. Dr. Torley shares how the book "The Five Dysfunctions of a Team" has influenced her leadership style. Dr. Torley is inspired by the innovative ideas and enthusiasm of her team members. She expresses concern about the impact of remote work on creativity, problem-solving, and personal development. The company is focused on putting patients at the center of their mission. They have a strong focus on community outreach, with 70% employee participation in volunteering events. She shares a personal story about a family member's experience with cancer treatment to underscore the importance of improving patient experiences. This episode of the Life Science Success podcast provides insight into the innovative solutions Halozyme is developing and their commitment to patient-centered care.  

Send us a textIn this episode of Life Science Success my guest is Kristofer Mussar.   Kristofer graduated from University of Georgia with a PhD in Molecular Genetics where he focused on Epigenetics and Evolution. He simultaneously obtained his MBA from the Terry College of Business.  He is currently the Managing Director and COO of VectorBuilder Inc.   Kristofer Mussar, PhD, discusses his company Vector Builder and their innovative gene delivery methods. Vector Builder's platform is free to use and includes a design team for gene delivery methods. They are working on several R&D projects, including a capsid evolution for novel capsids, a bacterial backbone-free plasmid, and antibody-conjugated lipo nanoparticles with mRNA. Vector Builder emphasizes collaboration and treating researchers as collaborators. Mussar believes in the importance of genetics and personalized medicine. Vector Builder has a new software-based platform called Vector B in development.